[Clinical use of concurrent antagonists of aldosterone in patients with cardiac insufficiency].
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002208:Caproates; D002301:Cardiac Glycosides / Q000009:adverse effects / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004361:Drug Tolerance / Q000187:drug effects; D005003:Ethisterone / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D006929:Hyperaldosteronism / Q000150:complications / Q000175:diagnosis; D008297:Male; D008525:Medroxyprogesterone / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D011188:Potassium / Q000097:blood; D011374:Progesterone / Q000009:adverse effects / Q000627:therapeutic use*; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000009:adverse effects / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance / Q000187:drug effects
D002208:Caproates; D002301:Cardiac Glycosides; D004232:Diuretics; D006908:Hydroxyprogesterones; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D011374:Progesterone; D012964:Sodium; D008525:Medroxyprogesterone; D005003:Ethisterone; D011188:Potassium
Klinicheskoe primenenie knkurentnykh antagonistov al'dosterona u bol'nykh s serdechnoĭ nedostatochnost'iu.